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A Common Mechanism Mediates Long-Term Changes
in Synaptic Transmission
after Chronic Cocaine and Morphine
Antonello Bonci and John T. Williams and form inhibitory synapses on dopamine cells. Re-
lease of GABA from these terminals causes a GABAB-The Vollum Institute
mediated inhibitory postsynaptic potential (IPSP)Oregon Health Sciences University L474
recorded from the dopamine-containing neurons (John-Portland, Oregon 97201
son and North, 1992). Activation of D1 receptors on
these GABA-containing axon terminals augments the
GABAB-mediated IPSP (Cameron and Williams, 1993).Summary
In contrast, D1 antagonists inhibit the GABAB-mediated
IPSP. This observation suggests that D1 receptors canThe mesolimbic system is known to play a role in self-
be tonically activated by endogenous dopamine and isadministration of opioids and psychostimulants. Al-
consistent with neurochemical studies indicating thatthough morphine and cocaine act by separate cellular
dopamine is tonically released both in vivo and in vitromechanisms initially, the present study describes a
(Geffen et al., 1976; Korf et al., 1976; Paden et al., 1976;common change in synaptic regulation of dopamine
Cheramy et al., 1981; Robertson et al., 1991). Thus, thecells in the ventral tegmental area 1 week after termi-
D1 receptors in the VTA are ideally situated for study ofnation of chronic treatment with either drug. Normally,
the long-term effects of chronic drug treatment on D1D1 receptor activation augmented the amplitude of a
receptor activation. The purpose of this study is to deter-g-aminobutyric acid type B (GABAB) inhibitory post-
mine the long-term effects of chronic drug treatment onsynaptic potential (IPSP), but in drug-experienced ani-
the D1 regulation of GABAB IPSPs in dopamine cells ofmals, D1 receptor activation caused an inhibition of
the VTA.the GABAB IPSP. The inhibition was blocked by adeno-
sine A1 receptor antagonists and by agents that dis-
Resultsrupted the metabolism of cAMP. This long-lasting do-
pamine±adenosine interaction maybe one mechanism
Regulation of GABA Release by D1 Receptorsinvolved in dopamine-mediated craving and relapse
Is Reversed after Chronic Cocaineto drug-seeking behaviors.
Dopamine (30±100 mM, in the absence of reuptake
blockers) and the D1 agonists SKF82958 (1±10 mM) and
Introduction SKF38393 (10 nM to 10 mM) produced an increase in
the GABAB IPSP in dopamine cells of the VTA in slices
One of the actions of drugs of abuse is to foster repeated from saline-treated control animals as was previously
drug experiences over an extended period of time. Con- found in untreated animals (Figure 1). In contrast, all
siderable evidence suggests that opioids and psycho- three agonists (SKF82958 85298, SKF38393, and dopa-
stimulants act through the mesolimbic dopamine sys- mine) decreased the amplitude of the IPSP in slices from
tem to support repeated drug administration (Wise and animals chronically injected with cocaine (10 mg/kg,
Rompre, 1989). One long-term effect of chronic opioids once per day for 2 weeks) and tested 7±10 days after
or psychostimulants is the phenomenon of sensitization termination of cocaine treatment. The D1 receptor an-
in which there is an increased sensitivity to drug for tagonists SCH23390 (1 mM, Figure 1) and cis-flupen-
weeks or months after termination of initial treatment thixol (10 mM, data not shown) decreased the IPSP
(Robinson and Becker, 1986; Robinson and Berridge, in slices from saline-treated animals (cis-flupenthixol:
1993). The development of sensitization is dependent 226.4% 6 1.1%, n 5 4), but increased the IPSP in
on the mesolimbic dopamine system and can occur slices from cocaine-treated animals (cis-flupenthixol:
following injection of either opioids or psychostimulants 28.9% 6 1.5%, n 5 4).
directly into the ventral tegmental area (VTA) (Kalivas Both D1 receptor activation and forskolin stimulate
and Stewart, 1991; Kalivas and Duffy, 1993a, 1993b). adenylyl cyclase (Stoof and Kebabian, 1981) and aug-
Expression of sensitization requires injection of direct ment the GABAB IPSP (Cameron and Williams, 1993).
or indirect dopamine agonists into nucleus accumbens Forskolin (1 and 10 mM) had the same effect as dopa-
(Kalivas and Stewart, 1991; Kalivas and Duffy, 1993a, mine agonists in slices from both saline- and cocaine-
1993b). After chronic cocaine, iontophoretic application treated animals (Figure 1). The IPSP amplitude was
of D1 agonists in vivo is more effective at producing increased in slices from saline-treated animals and de-
inhibition of both spontaneous and glutamate-induced creased in animals 7±10 days following the end of co-
firing of neurons in the nucleus accumbens (Henry and caine treatment. This observation indicates that the al-
White, 1991, 1995). In addition, transgenic animals lack- tered response to D1 receptor activation was mimicked
ing D1 receptors do not exhibit either an acute effect by direct activation of adenylyl cyclase.
or sensitization to cocaine (Xu et al., 1994). These results
indicate the importance of D1 receptors in psychostimu- Regulation of GABA Release by D1 Receptors
lant and opioid action, but the cellular mechanism and Is Reversed after Chronic Morphine
other neuronal circuits that contribute to sensitization Modulations of the GABAB IPSP by D1 agonists (dopa-
following chronic treatment have not been identified. mine, SKF82958, and SKF38393), SCH23390, and for-
Axons of the g-aminobutyric acid (GABA)-containing skolin in slices from animals that were treated with mor-
phine (10 mg/kg, once per day for 1 week) tested 7±10neurons in the nucleus accumbens project to the VTA
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Figure 1. The D1 Receptor Augmentation of
the GABAB IPSP Is Qualitatively Changed
7±10 Days after Termination of Chronic Co-
caine or Morphine Treatment
(A) An experiment taken from a saline-treated
animal, in which the D1 agonist SKF82958
(1 mM) increased the amplitude of the IPSP
and the D1 antagonist SCH23390 (1 mM) de-
creased the IPSP. The amplitude of the
GABAB-mediated IPSP is plotted as a func-
tion of time. During the period indicated by
the bars, the drugs in the indicated concen-
tration were superfused. In the inset are
IPSPs (average of three) taken from the peri-
ods indicated.
(B) A similar experiment as shown in (A), in a
slice taken from a morphine-treated animal.
In this experiment, SKF82958 depressed the
IPSP and SCH23390 reversed this de-
pression.
(C) Summarized data from similar experi-
ments shown in (A) and (B). In this and other
figures, the bars are the average change in
IPSP amplitude using each cell as its own
control. The number of cells for each experi-
ment is indicated beside each bar. The
hatched bars are from saline-injected animals
tested 1 week after the last injection, stippled
bars are from cocaine-treated animals tested
1 week after the last cocaine injection (co-
caine), and the closed bars are from animals
treated with morphine and tested 1 week after
treatment (morphine). The effect of each of
the dopamine agonists tested was an aug-
mentation in slices from saline-treated ani-
mals and an inhibition in slices from drug-
treated animals. The effect of forskolin (10
mM) was likewiseaffected in slices from drug-
treated animals. The effect of the D1 antago-
nist was also the opposite in slices from sa-
line- and drug-treated animals. The numbers
indicate the number of cells tested, one cell
per slice.
days after the last injection were almost identical to Lazarena et al., 1985; Egawa et al., 1988; Rosenberg
and Dichter, 1989; Rosenberg et al., 1994). Adenosinethose from cocaine-treated animals (Figure 1). That is,
dopamine, SKF82958, SKF38393, and forskolin de- acting at A1 receptors inhibits transmitter release in
creased and SCH23390 increased the IPSP, just oppo- many areas of the CNS (Dunwiddie, 1985; Mitchell et
site to the response observed in the saline controls. This al., 1993; Dunwiddie and Diao, 1994; Manzoni et al.,
altered response to D1 receptor activation and forskolin 1994; Gereau and Conn, 1994) including theGABAB IPSP
was observed in 75 out of 77 animals tested. in the VTA (Wu et al., 1995). Thus, the activation of A1
receptors could be mediated via an increase in adeno-
sine subsequent to the rise in cAMP following D1 recep-Adenosine Mediates D1 Inhibition of GABA
tor activation. To test this hypothesis, we treated slicesRelease after Chronic Drug Treatment
with the adenosine (A1) receptor antagonists 8-cylco-The interaction between D1 receptor activation and
pentyltheophylline (8CPT, 1 mM) or 8-cyclopentyl-1,adenosine was investigated because an increased pro-
3-dipropylxanthine (DPCPX, 1 mM) for 5±10 min (Figureduction of cyclic AMP (cAMP) would be expected with
2). This treatment changed the action of dopamine fromboth D1 receptor activation and forskolin (Stoof and
an inhibition to an augmentation in slices from drug-Kebabian, 1981), and it is known that cAMP can be
metabolized to adenosine (Barber and Butsher, 1981; treated animals (Figure 2). In the presence of 8CPT (1
Chronic Drug Treatment Augments Adenosine Tone
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Figure 2. The Decrease of the GABAB IPSP Caused by Dopamine
after Chronic Drug Treatment Was Reversed by the A1 Receptor
Antagonist DPCPX Figure 3. The Effects of Chronic Drug Treatment on the D1 Regula-
(A) Experiment taken from a chronic morphine-treated animal.Dopa- tion of the GABAB IPSP Are Blocked by the Adenosine Receptor
mine (30 mM) produced a decrease of the IPSP. Superfusion with Antagonist 8CPT and the Phosphodiesterase Inhibitor RO201724
DPCPX (1 mM) augmented the IPSP, and after DPCPX, dopamine
(A) After blockade of A1 adenosine receptors with 8CPT (1 mM),
(30 mM) now further augmented the IPSP. In the inset are shown
SKF38393 (1 mM), and forskolin (10 mM) caused an augmentation
the average of three IPSPs taken during the periods indicated by in the IPSP in slices from all treatment groups. Similarly, the augmen-
the numbers. tation of the IPSP caused by SCH23390 (1 mM) in drug-treated
(B) Normalized and averaged data, from chronic cocaine (n 5 2) animals was reversed to an inhibition by 8CPT.
and morphine (n 5 2) treated animals, showing the reversal of the (B) Similar observations as shown in (A) were made after treatment
dopamine effect after DPCPX. The percent change from control was of the slices with RO201724 (200 mM) for 10 min. In RO201724, the
determined by averaging seven control IPSPs and dividing each response to SKF38393 (1 mM), forskolin (10 mM), and SCH23390
IPSP by this mean value. (1 mM) were the same in all groups of animals. Forskolin (1 mM) had
a similar effect in slices from all three treatment groups (saline, 28%
6 8%, n 5 4; cocaine, 21% 6 5%, n 5 4; morphine, 28% 6 6%,mM), SKF38393 (1 mM) and forskolin (10 mM) also aug-
n 5 4).
mented the IPSP (Figure 3A). In addition, the augmen- (C) Shows concentration response curves to the D1 agonist
tation of the IPSP induced by SCH23390 (1 mM) in slices SKF38393 in slices from saline- (closed circles), cocaine-, and mor-
from drug-treated animals was also reversed to an inhi- phine-treated animals (open circles). Data from untreated animals
(closed triangles) were taken from a previous publication that didbition in the presence of 8CPT (1 mM, Figure 3A). Identi-
not include RO201724 in the superfusion solution (Cameron andcal results were obtained after treatment of slices with
Williams, 1993). The line is a least squares fit to the data from theRO201724 (200 mM, 10 min, Figure 3B), an inhibitor of
saline-treated animals. There was no significant difference between
cAMP-dependent phosphodiesterase (Beavo and Reif- the results obtained between any of the groups of animals. Each
synder, 1990). data point is obtained from at least four cells from four different
The D1 receptor- and forskolin-mediated augmen- animals.
tation of the IPSP was determined under conditions in
which adenosine tone had been reduced with
RO201724. The concentration response curve to 3C) or from untreated animals (Cameron and Williams,
1993). Thus, chronic drug treatment did not seem toSKF38393 in slices from drug-treated animal groupswas
not different from either saline-treated controls (Figure affect the sensitivity of D1 receptors to activation by
Neuron
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Figure 4. AdenosineTone Is Greater in Slices
from Drug-Treated Animals
(A) The adenosine antagonist 8CPT and the
phosphodiesterase inhibitor RO201724 both
increased GABAB IPSP to a significantly
greater extent in slices from drug-treated ani-
mals than saline-treated controls (ANOVA,
p < 0.001). The amplitude of the IPSP was
measured 10 min after superfusion of 8CPT
(1 mM) and RO201724 (200 mM).
(B) Concentrat ion response curves to the
A1 receptor agonist N6-CPA in slices from
saline- (closed ci rcles), cocaine- (open
diamonds), and morphine-treated (open
squares) animals. The line is a least squares
fit to the data obtained from the saline-treated
animals. There was no significant difference between any of the groups. Each point is data obtained from at least four cells from four different
animals. All data was collected in the presence of RO201724 (200 mM) to reduced the levels of endogenous adenosine.
agonist. In addition, the augmentation of the IPSP by The link between the increased adenosine tone,
cAMP, and D1 receptors was further investigatedforskolin (1 and 10 mM) was not changed (Figure 3B).
by testing the effect of RO201724 after blockade of
D1 receptors with SCH23390 (1 mM). In SCH23390,Adenosine Tone Is Augmented after Chronic
RO201724 (200 mM) had no significant effect on the IPSPDrug Treatment
(1.2% 6 0.6%, n 5 4 cocaine-treated animals; data notThe GABAB IPSP itself was augmented by both 8CPT
shown). That is, reduction of cAMP formation by a D1and RO201724, an effect that was significantly larger
antagonist also blocked the augmentation of the IPSPin slices from drug-treated animals (Figure 4A). An in-
by disruption of cAMP metabolism. This experimentcrease in the sensitivity of adenosine receptors was not
suggests that tonic activation of D1 receptors main-responsible for the augmented response to 8CPT and
tained a level of cAMP that was metabolized to adeno-RO201724 in drug-treated animals because the inhibi-
sine. This cAMP-dependent pool of adenosine may ac-tion of the IPSP caused by an exogenously applied ago-
count for greater adenosine tone in drug-treatednist was not changed (Figure 4B). The A1 receptor ago-
animals.nist N6-cyclopentyladenosine (N6-CPA) was tested in
To investigate further the suggestion that metabolismthe presence of RO201724 (200 mM) to reduce the level
of cAMP to adenosine resulted in the augmented tone,of endogenous adenosine. There was no effect of this
the inhibition of the IPSP by superfused cAMP was de-agonist on the membrane potential. The EC50 for inhibi-
termined in the three groups of animals (saline, mor-tion of the IPSP was 63 6 12 nMin saline-treated animals
phine, and cocaine treated). Superfusion of cAMPand was not significantly different in either drug treat-
(0.01±1 mM) caused a concentration-dependent inhibi-ment group (Figure 4B). The sensitivity to N6-CPA was
tion of the IPSP that was significantly larger in slicesvery similar to that reported in rat VTA (Wu et al., 1995).
from drug-treated animals (Figure 6). Binding studiesThus, the altered response to D1 agonists and forskolin
indicate that cAMP has an extremely low affinity fordid not result from a change in the sensitivity of A1
adenosine receptors. cAMP (100 mM) caused only areceptors.
26% displacement of [3H]N6-phenylisopropyladenosineThe following agents were tested to investigate further
binding to a rat brain membrane preparation (Schwabethe source of the endogenous adenosine: probenecid
and Trost, 1980). These results suggest that the metabo-(100 mM), which among other actions is an inhibitor
lism cAMP to adenosine may be augmented in drug-of cAMP transport (Rosenberg et al., 1994; Beavo and
treated animals.Reifsnyder, 1990), and adenosine deaminase (0.4 U/ml),
the enzyme that converts adenosine to inosine (Haas
and Greene, 1988; Ragazzi et al., 1991; Linden, 1989). Discussion
Neither treatment had a consistent effect on the mem-
brane potential, although both increased the amplitude The primary observation made here was that activation
of D1 dopamine receptors has the opposite effect inof the IPSP. The increase in IPSP was significantly larger
in slices from drug-treated animals than from the saline drug-treated animals compared with controls. The
mechanism mediating this change involves the activa-controls (Figures 5A). After treatment of the slices with
either probenecid or adenosine deaminase, the re- tion of A1adenosine receptors. The fact that D1 receptor
activation augments GABA synaptic potentials in controlsponse to SKF38393, SCH23390, and forskolin in slices
from cocaine- and saline-treated animals were identical and inhibits them after chronic drug treatment is a dra-
matic functional change. D1 receptors play a necessary(Figures 5B and 5C). Thus, experiments with RO201724,
probenecid, 8CPT, and adenosine deaminase all sug- role in the development and maintenance of long-term
behaviors induced by psychostimulants and opioidsgest that the basal level of extracellular adenosine was
increased in slices from drug-treated animals and that (Robinson and Becker, 1986; Robinson and Berridge,
1993; Kalivas and Stewart, 1991; Kalivas and Duffy,this increased adenosine tone may result from metabo-
lism of cAMP. 1993a, 1993b). The molecular mechanisms that underlie
Chronic Drug Treatment Augments Adenosine Tone
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Figure 5. Probenecid and Adenosine Deaminase Had the Same Effect as the Adenosine Receptor Antagonist and Phosphodiesterase Inhibitor
on the IPSP and on the Regulation of the IPSP by Dopamine
(A) Summary of experiments that show that probenecid (100 mM) and adenosine deaminase (0.4 U/ml) augmented the IPSP in slices from
cocaine-treated animals to a significantly greater extent than untreated animals (ANOVA, p < 0.001). The amplitude of the IPSP was measured
15 min after the onset of superfusion of each of these agents.
(B) In the presence of probenecid (100 mM), the regulation of the IPSP by SKF38393 (1 mM), forskolin (10 mM), and SCH23390 (1 mM) was the
same in slices from cocaine-treated animals as untreated controls.
(C) A similar experiment as shown in (B), in the presence of adenosine deaminase (0.4 U/ml).
the persistent behavioral changes have centered on the
dopamine system. Dopamine receptors, adenylyl cy-
clase, cAMP-dependent kinase, and substrates for
cAMP-dependent kinase including transcription factors
have all been targets for these studies (reviewed by
Woolverton and Johnson, 1992; Nestler, 1992, 1993,
1994). Any one of these mechanisms may be required
to initiate the cascade of events leading to the augmen-
tation of adenosine tone found in the present study. The
fact that drugs with very different initial actions (cocaine
and morphine) result in the same long-term action sug-
gests that multiple synaptic mechanisms or pathways
(or both) may be involved.
In slices taken from animals tested 1 day after the last
cocaine injection, the effects of D1 agonists/antagonists
and forskolin were not significantly different from the
saline-treated animals (data not shown) and the aug-
mented adenosine tone developed during the week fol-
lowing termination of drug treatment. The period imme-
diately following drug treatment is complicated by
several phenomena including recovery from tolerance
and acute withdrawal (Henry et al., 1989). The delay in
the development of the altered adenosine tone after
termination of cocaine treatment could result from the
synthesis or transport (or both) of key molecules from
the afferent neurons in the nucleus accumbens to the
VTA. The persistence of augmented adenosine tone also
suggests a gene regulation mechanism.
Figure 6. Exogenous Application of cAMP Depresses the IPSP
Regulation of Endogenous Adenosine
(A) Plot of the IPSP amplitude as a function of time. During the
In the present study, an altered metabolism of cAMPperiod indicated by the bar, cAMP was superfused in the indicated
rather than up-regulation of dopamine receptors or ade-concentration. Traces below the plot are selected IPSPs taken dur-
ing the period indicated by the numbers. nylyl cyclase appears to result from chronic drug treat-
(B) Concentration response curves for cAMP in slices from saline ment (Figure 6). After blockade of adenosine receptors,
(closed circles), cocaine (open squares), andmorphine (open circles) there was no difference in the D1 receptor± or forskolin-
treated animals. The line is a least squares fit to the data obtained mediated augmentation of GABA release between slices
from the saline-treated animals. Each point is the average of at least
from control and drug-treated animals. Although D1 re-four experiments taken from four different animals. The asterisks
ceptor±driven adenylyl cyclase activity was required,indicate the concentrations at which cAMP had a significantly larger
effect in both drug treatment groups. the augmented level of adenosine resulted from a
Neuron
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change subsequent to the adenylyl cyclase. The regula- cAMP than adenosine was found extracellularly after
stimulation of cortical cultures with b-adrenergic recep-tion of extracellular adenosine content is dependent on
the balance between mechanisms that increase (trans- tor agonists (Rosenberg et al., 1994). In that study, the
increase in extracellular cAMP was also blocked withport and metabolism of adenosine nucleotides) and de-
crease (reuptake and metabolism) adenosine levels. probenecid, an agent known to inhibit cAMP efflux. The
same concentration of probenecid was effective in theIn the CA1 region of hippocampus, endogenous aden-
osine inhibits the glutamate-mediated excitatory post- present study and suggests that cAMP is transported
extracellularly before metabolism. The transport mecha-synaptic potential (EPSP) (Dunwiddie and Diao, 1994).
The basal concentration of endogenous adenosine was nism itself has not been characterized, although poten-
tial candidates include a nucleotide transporter, themul-estimated to be 140±200 nM, which approached the
EC50 for adenosine (600±760 nM; Dunwiddie and Diao, tidrug resistance transporter, and even adenylyl cyclase
itself (Krupinski et al., 1989; Rosenberg et al., 1994). An1994). Thus, endogenous adenosine is in a functionally
important range. In the hippocampus, blockade of the augmented efficiency of transport would be one poten-
tial mechanism to increase extracellular adenosine.adenosine receptor with 8CPT augmented the EPSP by
20% (Dunwiddie and Diao, 1994). In the present study, Another potential mechanism supported in part by
experiments with superfusion of cAMP is to increasethe augmentation of the GABAB IPSP caused by 8CPT
was smaller in slices from control animals (10%), but adenosine levels by increased metabolism of cAMP.
Ecto-59-nucleotidase is an enzyme that mediates thesubstantially larger in both cocaine- and morphine-
treated animals (32%). Since the EC50 of the stable final step in the extracellular metabolism to adenosine.
This key membrane-bound enzyme has been found onagonist N6-CPA and the augmentation of the synaptic
potentials by antagonists were comparable in the hippo- cholinergic nerve terminals (Cunha et al., 1992), on the
mossy fibers of hippocampus (Zimmermann et al., 1993),campus and the VTA, the resting concentration of en-
dogenous adenosine may be similar. In drug-treated and on the glomerular and mitral synapses within the
olfactory bulb (Schoen and Kreutzberg, 1995). It hasanimals, the resting levels of adenosine would be ex-
pected to be slightly higher that the 200 nM determined been suggested that this enzyme was only present near
synapses during development or at synapses that areby Dunwiddie and Diao (1994). Based on their results
(Dunwiddie and Diao, 1994), a concentration response actively turning over (Schoen and Kreutzberg, 1995). An
up-regulation of this enzyme on the GABA terminalscurve was constructed with an EC50 of 620 nM and a
slope factor of 1. This curve was used to estimate the after cocaine withdrawal could provide the anatomical
substrate for a localized increase in adenosine tone.increase in adenosine required to mediate an inhibition
after forskolin or D1 receptor activation in the drug-
treated animals. The resting concentration of adenosine Adenosine±Dopamine Interactions
Disinhibit Dopamine Cellswas calculated to be 300 nM, which is the concentration
required to cause a 32% inhibition. In drug-treated ani- Previous studies found that chronic psychostimulant
treatment did not change D1 receptor binding in themals, D1 receptor activation caused a 20% inhibition
of the IPSP (Figure 3C). After blockade of adenosine striatum, nucleus accumbens, or VTA (Peris et al., 1990),
and variable effects on the activity of adenylyl cyclasereceptors D1 agonists caused a 20% increase in the
amplitude of the IPSP (Figure 3A). Taken together, the in the nucleus accumbens and striatum have been re-
ported (Terwilliger et al., 1991; Mayfield et al., 1992;rise in adenosine concentration would be expected to
reach 72% of the peak inhibition (32% 1 20% 1 20%), Roseboom et al., 1990). This study supports evidence
for the lack of any change in the regulation of D1 recep-which would require a concentration of about
1.6 mM. tors or adenylyl cyclase after chronic cocaine treatment.
The results of the present study are entirely consistentThis is probably an overestimate of the increased
adenosine. First, it assumes that the increase in endoge- with in vivo studies measuring dopamine in nucleus ac-
cumbens and the VTA (Kalivas and Duffy, 1993a, 1993b).nous adenosine caused by forskolin or dopamine recep-
tors is similar to superfusing exogenous adenosine. In microdialysis studies, dopamine release in the VTA
was not different between control and cocaine with-Since the D1 receptorsare on the GABA-releasing termi-
nals, the local concentration of adenosine could be sub- drawn animals, whereas in nucleus accumbens, both
the basal and dopamine release in response to cocainestantially higher than elsewhere in the slice. Second,
this estimate also assumes that there is no interaction injection were augmented in withdrawn animals (Kalivas
and Duffy, 1993a, 1993b). The present study suggestsbetween the augmentation induced by forskolin and D1
receptors with the adenosine-mediated inhibition. Fi- that in cocaine- and morphine-treated animals, inhibi-
tion of GABA release through increased adenosine tonenally, the maximum augmentation of the IPSP induced
by D1 receptor activation is about 36% (Cameron and could disinhibit dopamine cells. Disinhibition of dopa-
mine cells would be expected to increase dopamineWilliams, 1993), an effect that is small compared with
the inhibition caused by A1 receptor activation (.80%). release in projection areas such as the nucleus ac-
cumbens.It appears that cAMP is the source for the increased
extracellular adenosine. We suggest that D1 receptors In contrast with thedisinhibition predictedby the pres-
ent results, the number of spontaneously active VTAlocalized on GABA terminals from nucleus accumbens
activate adenylyl cyclase to increase cAMP (Figure 7). cells found in anesthetized animals was decreased
10±14 days after withdrawal from cocaine treatmentThe metabolism of cAMP to adenosine could occur
within the GABA terminal or in the extracellular space (Ackerman and White, 1992). Comparisons of the obser-
vations made in vivo and in vitro is not possible, sinceand is a matter of speculation. About ten times more
Chronic Drug Treatment Augments Adenosine Tone
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Figure 7. Schematic Figure Illustrating the
Proposed Mechanism for Increased A1 Re-
ceptor Activation Following Chronic Drug
Treatment
D1 receptor activation increases the forma-
tion of cAMP, which is a substrate for the
nucleotide transporter. Once in the extracel-
lular space, cAMP is metabolized to adeno-
sine and acts on A1 adenosine receptors
to inhibit GABA release. Probenecid was
used to block the nucleoside transporter.
RO201724 was used to inhibit phosphodies-
terase. Adenosine deaminase was used to
metabolize endogenous adenosine to inosine. The A1 receptor antagonist 8CPT was used to block the adenosine receptor. Although each
of these agents have potential nonselective actions, all produced the same effect on the D1 receptor±mediated inhibition of the GABAB IPSP.
being placed in the recording chamber and superfused (1.5 ml/the afferent inputs were stimulated electrically in vitro
min) with warmed (358C) Krebs/bicarbonate buffer containing theand since it is not clear what factors regulate the sponta-
following: 126 mM NaCl, 2.5 mM KCl, 1.2 mM NaH2PO4, 1.2 mMneous activity of dopamine cells in anesthetized ani-
MgCl2, 2.4 mM CaCl2, 11 mM glucose, 21.4 mM NaHCO3 saturatedmals. The GABA inputs to VTA arise from the nucleus with 95% O2 and 5% CO2. Recordings were made with KCl (2 M)
accumbens where the activity in anesthetized animals is filled glass microelectrodes (20±50 MV) using standard techniques.
Identification of dopamine cells was made based on the physiologi-generally low. Under these conditions, GABAB-mediated
cal properties, including the presence of a regular spontaneoussynaptic regulation of activity in the VTA would be
firing activity, a large H current, and the GABAB-mediated IPSPlimited.
(previously described by Johnson and North, 1992). Bipolar tung-There is substantial evidence that dopamine is spon-
sten-stimulating electrodes were placed mediocaudal and rostral
taneously released from neurons in the VTA and sub- to the VTA. To evoke synaptic potentials, neurons were maintained
stantia nigra both in slices and in vivo, although the at a membrane potential of 260 to 265mV by injecting hyperpolariz-
ing current (10±20 pA) and a train of stimuli (500 ms at 70 Hz for 143mechanism for spontaneous release ineach preparation
ms, i.e., 10 stimuli) ranging from 0.5±1.5 mA were delivered at 60 sis not completely understood (Geffen et al., 1976; Korf
intervals using a constant current stimulation unit.et al., 1976; Paden et al., 1976; Cheramy et al., 1981;
Drugs were applied in known concentrations to the superfusionRobertson et al., 1991). It appears that there is no corre-
medium. In experiments examining the GABAB synaptic potential,lation between the rate of spontaneous activity and re- the superfusion medium contained 2-amino-5-phosphonopentanoic
lease of endogenous dopamine in the VTA. Although acid (AP5, 100 mM), 6-cyano-2,3-dihydroxy-7-nitro-quinoxaline
(CNQX, 10 mM), picrotoxin (100 mM), and eticlopride (100 nM) toamphetamine-induced dopamine release has been
block fast NMDA, AMPA,GABAA, anddopamine D2 mediated synap-shown to inhibit both dopamine cell activityby activation
tic potentials, respectively. There was no effect of this solution onof D2 receptors (Mercuri et al., 1989) and GABA cell
the firing rate or membrane potential of the dopamine cells used inactivity in the substantia nigra zona reticulata by activa-
the present study. The same observation has been reported using
tion of D1 receptors (Timmerman and Abercrombie, a similar mixture of antagonists in rat VTA (Johnson and North,
1995), dopamine-mediated synaptic inhibition evoked 1992). IPSPs were blocked by the GABAB receptor antagonist
CGP35348 (100 mM). The stimulus intensity was adjusted such thatby electrical stimulation is rare or has failed altogether
IPSPs recorded in all groups of animals had the same range of(Johnson and North, 1992: D. L. Cameron and J. T. W.,
amplitudes, so that all drug induced effects are presented as aunpublished data). As such, if disinhibition of dopamine
percentage change from control and can be compared directly.cells occurs, there would no increase in an opposing
Experiments with SKF38393, SKF82958, and SCH23390 required
D2-mediated inhibition caused by an augmented release separate groups of slices, since the washout time of these drugs
of dopamine. In fact, there was no change in the dopa- was too slow to allow repeated administrations. Cocaine, AP5, and
picrotoxin were obtained from the Sigma Chemical Company. CNQXmine levels after cocaine withdrawal as measured by
and eticlopride were obtained from Research Biochemicals, Interna-dialysis experiments (Kalivas and Duffy, 1993b).
tional. Results in the text and figures are presented as the mean 6Sensitization to psychostimulants is a complex phe-
SEM. The percent changes presented in all bar graphs are deter-nomenon involving interactions between several CNS
mined as follows: (IPSP amplitude in the presence of drug)/(IPSP
areas (Robinson and Becker, 1986; Robinson and Ber- amplitude in control)*100±100. The average of four IPSPs was taken
ridge, 1993). This study suggests that neurochemical in control just before adding the drug and again after the effects of
the drug had reached steady state (5±20 min). A p value of less thanmechanisms that may be unrelated to the initial action
0.05 was taken as indicating statistical significance.of cocaine or opioids on the dopamine system, such as
Animals were given once daily intraperitoneal injections of salinethe augmentation of adenosine tone, can result in a
(n 5 16), cocaine (10 mg/kg) for 2 weeks or morphine (10 mg/kg)
persistent change in the synaptic regulation of dopa- for 1 week. Some cocaine-treated animals (n 5 4) were tested the
mine cell activity. first day after the last injection and called the chronic cocaine group.
Most experiments were carried out 7±10 days after the last drug
Experimental Procedures injection (cocaine, n 5 33; morphine, n 5 18).
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